Some of the competitors of Abbott Laboratories in the United States include Johnson & Johnson (JNJ), Medtronic (MDT), and Thermo Fisher Scientific (TMO).
For diversified exposure to Abbott Laboratories (ABT), investors can invest in the iShares Global Healthcare ETF (IXJ), which has 1.7% of its total holdings in ABT. Investors can also invest in the iShares US Healthcare ETF (IYH) and get exposure to ABT, which accounts for 2.4% of IYH’s total holdings.
Now let’s look at Abbott Laboratories’ diagnostic products segment.
View more information: https://marketrealist.com/2015/12/abbott-laboratories-leader-nutritional-products/